anecortave acetate has been researched along with Eye Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Joussen, AM; Kirchhof, B | 1 |
| Toris, C | 1 |
2 other study(ies) available for anecortave acetate and Eye Disorders
| Article | Year |
|---|---|
[Angiogenesis in ophthalmology. A theme with a future].
Topics: Adult; Angiogenesis Inhibitors; Antineoplastic Agents; Choroidal Neovascularization; Corneal Neovascularization; Diabetic Retinopathy; Endothelial Growth Factors; Eye Diseases; Humans; Infant, Newborn; Intercellular Signaling Peptides and Proteins; Lymphokines; Macular Degeneration; Metalloendopeptidases; Neovascularization, Pathologic; Organic Chemicals; Platelet-Derived Growth Factor; Pregnadienediols; Retinal Neovascularization; Retinopathy of Prematurity; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2003 |
Association for Ocular Pharmacology and Therapeutics--Seventh Meeting. 3-5 February 2005, Catania, Italy.
Topics: Chemistry, Pharmaceutical; Clinical Trials, Phase III as Topic; Eye Diseases; Humans; Macular Degeneration; Molecular Structure; Ophthalmic Solutions; Pregnadienediols; Receptors, Vascular Endothelial Growth Factor; Societies, Medical | 2005 |